Assignee
AIHOL CORP
US·9 granted patents·5 pending applications·9 citations·filing 2013–2025
Top patents by PatentIndex Score
14 records- 0193US12281133B2Hyaluronan conjugateAIHOL CORP·Filed 2023·Granted Apr 22, 2025·2 cites·4 claims
- 0291US11643431B2Uses of hyaluronan conjugateAIHOL CORP·Filed 2021·Granted May 9, 2023·4 cites·12 claims
- 0387US12521351B1Delayed release oral pharmaceutical compositionAIHOL CORP·Filed 2024·Granted Jan 13, 2026·1 cites·18 claims
- 0473US2024415973A1Uses of hyaluronan conjugatesAIHOL CORP·Filed 2024·Application pending·0 cites
- 0572US12128108B2Hyaluronan conjugates and uses thereofAIHOL CORP·Filed 2022·Granted Oct 29, 2024·0 cites·27 claims
- 0672US2026090996A1Delayed release oral pharmaceutical compositionAIHOL CORP·Filed 2025·Application pending·0 cites
- 0768US10471151B2Composition for use in treating and preventing inflammation related disorderAIHOL CORP·Filed 2018·Granted Nov 12, 2019·1 cites·7 claims
- 0863US2024050579A1Hyaluronan-nimesulide conjugate for treating locally advanced or metastatic tumorsAIHOL CORP·Filed 2023·Application pending·0 cites
- 0962US11524079B2Hyaluronan conjugates and uses thereofAIHOL CORP·Filed 2020·Granted Dec 13, 2022·0 cites·7 claims
- 1059US2022401567A1Uses of hyaluronan conjugateAIHOL CORP·Filed 2022·Application pending·0 cites
- 1158US9539265B2Pharmaceutical formulation containing glycosaminoglycanAIHOL CORP·Filed 2013·Granted Jan 10, 2017·1 cites·17 claims
- 1255US10709731B2Materials for treating and preventing mucosa related diseaseAIHOL CORP·Filed 2016·Granted Jul 14, 2020·0 cites·6 claims
- 1348US11458204B2Method for improving substitution rate and/or substitution efficiency of hyaluronan-drug conjugatesAIHOL CORP·Filed 2020·Granted Oct 4, 2022·0 cites·19 claims
- 1439US2016193343A1Composition for use in treating and preventing inflammation related disorderAIHOL CORP·Filed 2016·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →